Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly

By Yang Lily P.H.   Keating Gillian M.  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1745-1769

Adis International

Access to resources Recommend Favorite

Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly

By McKeage K.   Cheer S.   Wagstaff A.J.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2473-2499

Adis International

Access to resources Recommend Favorite

SC octreotide resolved prolonged chylothorax after surgery for congenital heart disease

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

The efficacy of octreotide LAR (long acting release) treatment in patients with somatotropinoma, and mixed pituitary tumours

By Waśko Ryszard   Bolko Paweł   Owecki Maciej   Jaskuła Magdalena   Sowiński Jerzy  

Pharmacy World and Science, Vol. 26, Iss. 6, 2004-12 ,pp. : 324-327

Springer Publishing Company

Access to resources Recommend Favorite

Everolimus [RAD 001], in combination with octreotide long-acting repeatable (LAR), shows promising antitumour activity

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite